Nuvectis Pharma, Inc. Common Stock

NVCTNASDAQ • USD
ThemeHealthcare - Oncology›Targeted Therapy & Precision Oncology
9.54 USD
↘ 0.13 (1.34%)AT CLOSE (11:59 AM EDT)
9.52
↘ 0.02 (0.16%)
POST MARKET (AS OF 04:16 PM EDT)
Post Market
AS OF 04:16 PM EDT
9.52
↘ 0.02 (0.16%)
🔴Market: CLOSED
Open?$9.56
High?$9.78
Low?$9.33
Prev. Close?$9.67
Volume?74.4K
Avg. Volume?104.2K
VWAP?$9.58
Rel. Volume?0.71x
Bid / Ask
Bid?$7.67 × 100
Ask?$11.37 × 100
Spread?$3.70
Midpoint?$9.52
Valuation & Ratios
Market Cap?253.1M
Shares Out?26.5M
Float?15.5M
Float %?58.4%
P/E Ratio?N/A
P/B Ratio?17.80
EPS?-$1.12
Dividend?0.00%
Ex-Dividend?N/A

Shares of Nuvectis Pharma, Inc. Common Stock (NVCT) are trading at $9.54. Our models show a "Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Furthermore, NVCT is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
Themes
Healthcare - Oncology›Targeted Therapy & Precision OncologyHealthcare - Genomics & Precision Medicine›Precision Medicine Platforms
Employees
13
Market Cap
253.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.nuvectis.com
Listed
2022-02-04
Address
1 BRIDGE PLAZA, SUITE 275
FORT LEE, NJ 07024
Phone: 360-837-7232
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
97
Momentum?
50
Short Sent.?
28
Piotroski F-Score?0/9Weak
Altman Z-Score?4.75Safe
Confidence?45%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?9.22%Elevated
Short Interest?1.4M
Days to Cover?11.0
Free Float15.5M
Avg Daily Volume130.2K
Settlement Date2026-05-15
Financial Health
Current Ratio?2.27Strong
Quick Ratio?2.27Strong
Cash Ratio?2.25Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
9
17.80HIGH▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-8.1CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-208.1%WEAK▾
ROA?
S&P
3
-116.5%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$227.9M
Fundamentals ratios updated end of day
MarketsMoversWatchlist